Market Tracker

02/20 7:53am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

26.10
Delayed Data
As of Feb 17
 -0.10 / -0.38%
Today’s Change
12.15
Today|||52-Week Range
27.95
+3.37%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close26.20
Today’s open26.15
Day’s range25.65 - 26.45
Volume363,623
Average volume (3 months)547,938
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+206.25%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio16.2
Price/Sales4.76
Price/Book10.76

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.03+0.29%
EBSEmergent BioSolution...-0.54-1.75%
FWPForward Pharma A/S+0.09+0.30%
DERMDermira Inc+0.60+1.81%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts